Surveillance for hospitalizations with infection-related diagnoses after chemotherapy among breast cancer patients diagnosed before age 65

Chemotherapy

Volumn 50, Issue 4, 2004, Pages 157-161

  Polednak, Anthony P ^a,b  

^a CT Department of Public Health ^*  (United States)

^b Connecticut Dept of Public Health ^*  (United States)

Author keywords

Chemotherapeutic agents; Febrile neutropenia; Risk factors for complications

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DRUG FEVER; FEASIBILITY STUDY; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; INTESTINE INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEUTROPENIA; PILOT STUDY; PRIORITY JOURNAL; SARCOIDOSIS; VIRUS HEPATITIS; VIRUS INFECTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; BREAST NEOPLASMS; CONNECTICUT; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INFECTION; MIDDLE AGED; NEUTROPENIA; POPULATION SURVEILLANCE; SEER PROGRAM;

EID: 8344253528     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080688     Document Type: Article

References (21)

1. Karthus M, Buchheidt, Hiddermann W, Donnelly JP, Krcmery V, Schiel X, Wilhelm M, Helmerking M: European surveillance of infections in cancer patients - ESIC. Chemotherapy 1999;45:237-241.
2. Du XL, Osborne C, Goodwin JS: Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002;20:4636-4642.
3. Harlan LC, Abrams J, Warren JL, Clegg L, Stevens L, Ballard-Barbash R: Adjuvant therapy for breast cancer: Practice patterns in the community. J Clin Oncol 2002;20:1807-1817.
4. Polednak AP: Chemotherapy of nonelderly breast cancer patients by poverty rate of area of residence in Connecticut. Breast Canc Res Treat 2004;83:245-248.
5. Polednak AP: How frequent is postmastectomy breast reconstructive surgery? A study linking two statewide databases. Plast Reconstr Surg 2001;108:73-77.
6. Khan SA, Wingard JR: Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr 2001;29:31-36.
7. Marchetti O, Calandra T: Infections in neutropenic cancer patients. Lancet 2002;359:723-724.
8. Charlson ME, Pompei P, Alex KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-383.
9. Norusis MJ: SPSS Advanced Statistics 6.1. Chicago, SPSS Inc, 1994.
10. Peduzzi P, Concato J, Feinstein AR, Holford TR: Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of repression estimates. J Clin Epidemiol 1995;48:1503-1510.
11. Bradburn MJ, Clark TG, Love SB, Altman DG: Survival analysis. III. Multivariate data analysis - choosing a model and assessing its adequacy of fit. Br J Cancer 2003;89:605-611.
12. Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States, 1975-1999. J Natl Cancer Inst 2002;94:1626-1634.
13. Pizzo PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;323:1323-1332.
14. Karthus M, Carratala J, Jurgens H, Ganser A: New strategies in the treatment of infectious complications of haematology and oncology: Is there a role for outpatient antibiotic treatment of febrile neutropenia? Chemotherapy 1998;44:427-435.
15. Watkins M, Lapham S, Hoy W: Use of a medical center's computerized healthcare database for notifiable disease surveillance. Am J Public Health 1991;81:637-639.
16. Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H: Oral versus intravenous empirical antimicrobial therapy for fever for patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999;341:312-318.
17. Partridge AH, Burstein HJ, Winer EP: Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr 2001;30:135-142.
18. Finberg RW, Talcott JA: Fever and neutropenia - How to use a new treatment strategy. N Engl J Med 1999;341:362-363.
19. Elting LS, Rubenstein EB, Rolston KVI, Bodey GP: Outcomes of bacteremia in patients with cancer and neutropenia. Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-259.
20. Nyhlen A, Ljungberg B, Nilsson-Ehle I, Odenholt I: Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli. Chemotherapy 2002;48:71-77.
21. Nyhlen A, Ljungberg B, Nilsson-Ehle I, Odenholt I: Postantibiotic effect of meropenem and ciprofloxacin in the presence of 5-fluorouracil. Chemotherapy 2002;48:182-188.